Why Cannabis Deregulation Puts America First

Introduction: What “America First” Means in Cannabis Policy

“America First” in cannabis isn’t about ideology—it’s about economic efficiency, public safety, consumer protection, and respect for federalism. Today’s patchwork of laws—where cannabis is legal in many states but still federally illegal—creates costly barriers: fragmented, intrastate-only supply chains; limited access to banking and payments; uneven quality testing; and confusion for communities deciding whether to allow local stores. Deregulation—by which I mean removing federal barriers so states and markets can function coherently—would put the country on stronger footing by lowering costs, raising standards, and honoring states’ choices.

To see why, we’ll walk through: (1) interstate commerce restrictions and the Dormant Commerce Clause fight; (2) federal banking obstacles and what SAFER Banking aims to fix; (3) quality-control testing and how science-based standards have transformed consumer expectations; and (4) why ending with states’ rights and local choice is essential to an American approach.

1) Interstate Commerce: The Cost of Siloed Markets

The balkanization problem

Even where cannabis is legal, products cannot cross state lines, forcing every legal state to duplicate growing, manufacturing, and distribution—no matter their climate, costs, or expertise. That drives up prices and stifles innovation, particularly in states with poor cultivation conditions. Analysts have described the resulting markets as “entirely balkanized,” blocking regional specialization and economies of scale.

Several states have explored interstate compacts that would allow legal shipments between legal states once certain federal “triggers” occur (e.g., DOJ tolerance or legalization). California passed SB 1326 to prepare for interstate agreements; Oregon’s SB 582 did likewise; Washington has considered similar measures. These laws anticipate a future in which cannabis can be shipped along “green routes” that avoid non-legal states during transit.

Dormant Commerce Clause: Courts are weighing in

The Dormant Commerce Clause (DCC) limits state protectionism in interstate trade. In cannabis, courts have increasingly applied the DCC to strike down residency requirements that favor locals over out-of-state owners. Landmark decisions include the First Circuit’s ruling in Northeast Patients Group v. Maine (invalidating residency rules for medical dispensaries) and the Missouri federal court injunction in Toigo v. DHSS (blocking a majority-ownership residency requirement).

More recently, the Second Circuit held the DCC applies to cannabis despite federal illegality, complicating state attempts to prefer in‑state applicants; other circuits have shown skepticism, underscoring an active split. These rulings don’t open interstate cannabis shipping yet—but they chip away at state-level protectionism, signaling that once federal barriers lift, states likely cannot wall off their markets from out-of-state competitors.

America-first takeaway : Free and fair interstate commerce is a signature U.S. strength. Deregulation would unlock regional specialization (e.g., low-cost cultivation in ideal climates), reduce duplication, and lower consumer prices —all while preserving state oversight. [reason.org]

2) Federal Banking: Safety, Transparency, and Growth

The current bind

Because cannabis remains illegal federally, many banks and card networks won’t serve cannabis businesses . That forces legitimate operators to run cash-heavy operations—risking robbery, complicating payroll/taxes, and hindering transparency. The result is a public‑safety problem and a compliance quagmire. Even institutions willing to help must follow FinCEN’s 2014 guidance : enhanced due diligence, continuous Suspicious Activity Reports (SARs) every 90 days, and specialized “marijuana limited/priority/termination” filings—an administrative burden that keeps fees high and providers sparse.

FinCEN’s latest data update (covering activity through December 2024) shows more banks and credit unions filing cannabis SARs, but reporting burdens persist, and many institutions still decline accounts. The system has grown, yet it remains a patchwork that limits lending, payments, and insurance—core ingredients of a modern economy.

SAFER Banking: A pragmatic fix

The bipartisan SAFER Banking Act (an evolution of SAFE) aims to give banks a federal safe harbor for serving state-legal cannabis firms—expanding depository services, payroll, merchant processing, and credit. As of mid‑2025 it had cleared Senate Banking Committee and drew support from 32 state attorneys general who framed it as public-safety and tax-collection policy, not federal legalization.

Separate but related, the DEA’s May 2024 proposed rule to move marijuana to Schedule III (reflecting HHS’s recommended rescheduling) would change tax treatment (ending §280E) and expand research, but would not itself legalize interstate commerce or eliminate CSA criminal provisions. Rescheduling would still require DEA registrations and controls unless marijuana were fully descheduled.

America-first takeaway : Deregulation—including passing SAFER and modernizing federal treatment—would reduce crime risk, increase transparency, and lower costs. It strengthens tax collection, facilitates compliance, and coordinates state-regulated commerce with mainstream finance.

3) Quality Control: From Label Claims to Consumer Confidence

Patchwork testing to science‑based standards

Legal markets introduced mandatory lab testing for potency, contaminants (pesticides, heavy metals, residual solvents), and microbials/mycotoxins—dramatically improving safety over illicit markets. States vary widely: California and Oregon test for large panels of pesticides; Colorado and Washington are strict on potency variance. Independent comparisons show consistent differences in what and how states require testing.

Testing maps from industry labs and media confirm the lack of federal standardization: the number of pesticide analytes, microbial categories, metals, and solvents can diverge across jurisdictions. These differences complicate compliance for multi-state operators and confuse consumers who expect uniform label accuracy.

To close gaps, scientific bodies have moved: AOAC International’s Cannabis Analytical Science Program (CASP) is developing consensus methods (SMPRs), proficiency testing, and best-practices to increase reliability of potency and safety testing. ASTM International (Committee D37) and USP have likewise pushed toward harmonized standards for cannabis quality, recognizing that consistent, validated methods build trust in product labels—and enable interstate trade once legal.

Expectations have changed

Regulated testing reshaped consumer expectations: verified THC/CBD potency, screened contaminants, and increasingly terpene disclosure. During the 2019 vaping lung-injury crisis, strong testing and track‑and‑trace kept dangerous adulterants largely out of licensed markets—an example of compliance protecting public health. Over time, consumers have come to expect that legal products are tested and traceable, raising the bar for the entire sector.

America-first takeaway : National deregulation coupled with harmonized, science-based standards would enhance consistency across states, reduce recalls, and build brand trust. That’s good for patients, adult consumers, and for U.S. manufacturers vying with global competitors. [usp.org], [aoac.org]

4) Jobs, Tax Revenues, and Market Reality

Legalization has expanded: 24 states + D.C. allow adult (recreational) use; around 40 states + D.C. allow medical. Industry analyses and legislative trackers confirm the broad footprint, with revenues and jobs rising alongside regulated programs (notwithstanding cyclical headwinds). A clearer federal framework would reduce friction and help legitimate businesses thrive.

Yet the federal-state conflict persists. The DOJ rescinded the 2013 Cole Memo in 2018, though current approaches often resemble its priority model: focusing enforcement on diversion, youth access, criminal organizations, and violence. Until Congress or DEA finalizes changes, the CSA still constrains interstate trade and keeps ambiguity alive.

America-first takeaway : Deregulation would align federal policy with on‑the‑ground reality—lowering costs, expanding research, ending §280E’s distortion, and allowing the U.S. to lead in a sector already employing hundreds of thousands.

5) Public Safety & Consumer Protection: Banking + Testing = Better Outcomes

When businesses operate within the banking system and under standardized testing regimes, safety improves :

• • Cash reduction : Banking access reduces robbery risk, helps law enforcement track funds, and makes tax payment easier. That’s why bipartisan AGs back SAFER Banking.
  • Quality assurance : Harmonized AOAC/ASTM/USP methods mean labels match reality and contaminants stay out. Consumers expect verified potency and purity; national standards would cement those expectations.
  • Research and compliance : Rescheduling to Schedule III would ease research barriers and remove §280E for legal operators, while still leaving CSA controls unless Congress acts. That’s progress—but full clarity requires broader reform.

America-first takeaway : Bringing cannabis into transparent finance and evidence-based testing protects consumers and communities, replacing the shadow economy with accountability.

6) Economics of Interstate Commerce: Efficiency, Innovation, and Equity

Allowing interstate commerce would:

• • Lower production costs via regional specialization (e.g., outdoor cultivation in optimal climates; manufacturing hubs where labor and utilities are efficient).
  • Enable brand scale and consistent national quality through centralized R&D and validated methods.
  • Reduce waste and oversupply cycles by letting surplus in one state meet demand in another. Policy analyses and industry commentary point to this as a fix for west‑coast gluts.
  • Enhance consumer choice : more competition, better pricing, and availability of specialized products (medicinal formulations, rare terpene profiles).

To be clear, interstate commerce remains illegal under current federal law , and even with Schedule III , CSA controls would still apply unless marijuana were descheduled or Congress authorized interstate agreements. But preparing for legal interstate trade (as California and Oregon have) signals how deregulation can unlock American competitive advantages. [dea.gov], [vicentellp.com]

7) A Responsible Roadmap: Deregulation That Puts America First

A pragmatic, America-first deregulation plan would:

• • Enact SAFER Banking to normalize depository, payments, and lending for state‑legal operators; reduce cash crime risk; improve tax collection.
  • Finalize evidence‑based rescheduling or descheduling to enable research, end §280E, and clarify compliance—while recognizing that Schedule III alone doesn’t open interstate commerce.
  • Adopt national testing benchmarks through collaboration with AOAC/ASTM/USP, so multi‑state products meet consistent potency and contaminant standards—protecting patients and adult consumers.
  • Authorize interstate compacts (subject to federal approval) that respect state rules while leveraging regional strengths—an American solution rooted in commerce and federalism.

8) States’ Rights—and Communities’ Choice

Cannabis policy is uniquely federalist: states have led with medical and adult‑use programs, while the federal government has lagged. Deregulation should not force any state to legalize. Instead, it should respect states’ rights to permit or prohibit, and empower local communities to opt in or out of retail stores, cultivation sites, or manufacturing—based on local values, zoning, and public‑health priorities. Many states already allow municipalities to opt out or set buffers, caps, and separation rules. A national framework ought to formalize local control while eliminating federal obstacles that create crime risk and economic waste.

Ending with choice is critical. Communities that want no cannabis should have that power; communities that want a tested, taxed, and transparent market should not be punished by federal contradictions that keep commerce in the shadows. Deregulation in service of America First means:

• • States decide how to regulate, tax, and license—consistent with science-based quality and safety norms;
  • Local governments choose whether to host businesses and under what conditions;
  • Consumers and patients benefit from safe products, clear labels, fair prices, and accountable vendors.

That’s a pro‑safety, pro‑commerce, pro‑federalism approach fitting a nation built on interstate trade and local self‑determination.

Cannabis Deregulation is America First

Cannabis deregulation—done responsibly—puts America first by freeing interstate commerce, modernizing banking and compliance, standardizing quality, and honoring states’ rights and community choice. It lowers costs, boosts transparency, advances research, and protects consumers. Most importantly, it aligns law with lived reality across 24 adult‑use states and dozens of medical programs, replacing ambiguity with clarity and accountability.